National Survey on Implementation Patterns and Functional Needs for Hospital-Wide Glycemic Management Systems in the Chinese Mainland: Mixed Methods Study - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

National Assessment of Implementation Strategies and Functional Requirements for Comprehensive Glycemic Management Systems in Mainland China: A Mixed Methods Approach

  • By

  • Xiazi Wang

  • Jin Huang

  • Tianhui Xu

  • Zhe Zhang

  • Chenshuang Luo

  • Yaqiong Tan

  • Huiping Wang

  • Rong Xu

  • August 28, 2026

Share

  • 1

    Diabetes mellitus is a significant global health challenge, with 589 million adults affected in 2024, projected to rise to 853 million by 2050.

  • 2

    China has the highest number of diabetes cases worldwide, accounting for 148 million, followed by India and the United States.

  • 3

    Inadequate glycemic control in hospitalized patients can lead to severe complications, extended hospital stays, and increased mortality.

  • 4

    Hospital-wide glycemic management systems (HGMS) are essential for improving inpatient diabetes care through standardized and efficient monitoring.

  • 5

    Digital health innovations in HGMS support timely remote management by endocrinology specialists, enhancing patient safety and reducing hospital stays.

Original Source(s)

National Survey on Implementation Patterns and Functional Needs for Hospital-Wide Glycemic Management Systems in the Chinese Mainland: Mixed Methods Study

  • by Xiazi Wang, Jin Huang, Tianhui Xu, Zhe Zhang, Chenshuang Luo, Yaqiong Tan, Huiping Wang, Rong Xu

  • August 28, 2026

Related Content

TOFA may drive weight loss without reducing food intake

The oral compound increased energy expenditure, reduced fat mass, and improved metabolic measures in male mouse models.

Preoperative Factors Associated with Weight Loss and Recurrent Weight Gain after Bariatric Surgery: A Longitudinal Study in a UK Public Healthcare Setting

FDA authorizes continuous ketone monitor

Patients aged 2 years and older with diabetes are eligible to use the wearable.